Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease

Saved in:
Bibliographic Details
Published inThe Annals of pharmacotherapy p. 10600280221080986
Main Authors Choi, David K, Puangampai, Archariya, Rubin, David T
Format Journal Article
LanguageEnglish
Published United States 01.11.2022
Online AccessGet more information

Cover

More Information
ISSN:1542-6270
DOI:10.1177/10600280221080986